Business
Currency:USD
2023/FY
Stock NameRevenueRatio
Developing novel small molecule therapeutics to treat unmet medical needs in immune-mediated7M100.00%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States7M100.00%